Vivos Therapeutics VVOS Balance Sheet (2019-2026)

NASDAQ VVOS
$0.15 +0.02 (+12.23%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Vivos Therapeutics Quarterly Balance Sheet

Periods 27 quarters
Latest Jun 2026

Vivos Therapeutics reported total assets of $24.14M and total liabilities of $28.13M for the quarter ended Jun 2026, down 7.3% year over year. This balance sheet covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
28.53M24.03M17.83M12.70M6.72M3.52M7.05M3.94M1.00M1.64M2.61M6.90M6.31M6.26M2.34M4.40M3.10M2.03M2.11M1.80M
Cash & Current Investments
28.53M24.03M17.83M12.70M6.72M3.52M7.05M3.94M1.00M1.64M2.61M6.90M6.31M6.26M2.34M4.40M3.10M2.03M2.11M1.80M
Receivables - NetNet Receivables
3.83M1.20M1.00M0.79M0.87M0.46M0.32M0.33M0.23M0.20M0.53M0.40M0.45M0.43M0.72M1.63M2.13M1.58M1.80M1.44M
Receivables
3.83M1.20M1.00M0.79M0.87M0.46M0.32M0.33M0.23M0.20M0.53M0.40M0.45M0.43M0.72M1.63M2.13M1.58M1.80M1.44M
Prepaid Assets
1.60M1.57M2.25M2.06M2.12M1.45M1.35M1.07M0.77M0.62M0.47M0.55M0.63M0.78M0.55M0.69M0.56M0.77M0.94M1.00M
Current Assets
34.03M27.32M21.60M15.51M9.70M5.42M8.71M5.34M1.99M2.46M3.61M7.85M7.40M7.47M3.61M6.73M5.79M4.38M4.82M4.21M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
2.60M2.83M2.91M3.11M3.04M3.08M3.16M3.27M3.28M3.31M3.33M3.26M3.32M3.31M3.31M5.13M5.64M3.76M3.53M3.64M
Goodwill
2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M2.84M8.50M8.50M8.60M8.60M8.60M
Intangibles
0.35M0.34M0.33M0.32M0.31M0.30M0.46M0.45M0.43M0.42M0.41M0.40M0.38M0.41M0.36M2.23M2.17M4.04M3.84M3.64M
Goodwill & Intangibles
3.19M3.18M3.17M3.17M3.15M3.15M3.30M3.29M3.28M3.26M3.25M3.24M3.23M3.25M3.20M10.72M10.67M12.64M12.44M12.24M
Other Non-Current Assets
0.36M0.36M0.35M0.37M0.37M0.37M0.31M0.31M0.31M0.31M0.31M0.28M0.28M0.22M0.21M0.26M0.21M0.23M0.25M0.27M
Non-Current Assets
6.99M6.37M7.96M8.86M8.70M8.30M8.39M8.41M8.33M8.27M8.19M7.99M7.95M7.81M7.67M19.30M19.86M20.77M20.22M19.93M
Assets
41.02M33.69M29.56M24.38M18.40M13.72M17.10M13.75M10.32M10.73M11.80M15.84M15.35M15.28M11.28M26.03M25.64M25.15M25.04M24.14M
Liabilities
Current Liabilities
Accounts Payables
0.70M0.92M0.88M1.25M0.64M1.41M1.50M1.32M1.53M2.15M2.50M2.03M1.07M1.10M1.21M1.76M2.10M1.68M2.00M2.95M
Payables
0.70M0.92M0.88M1.25M0.64M1.41M1.50M1.32M1.53M2.15M2.50M2.03M1.07M1.10M1.21M1.76M2.10M1.68M2.00M2.95M
Accumulated Expenses
2.53M2.85M3.17M2.62M2.18M1.91M1.94M1.95M1.92M2.33M2.47M2.19M2.05M2.23M1.78M2.30M2.68M5.99M6.11M7.04M
Other Accumulated Expenses
0.36M0.29M0.14M0.13M0.16M0.28M0.33M0.22M0.15M0.20M0.48M0.67M1.01M0.99M0.85M1.23M1.20M
Short term Debt
1.27M1.26M0.16M0.34M8.35M7.30M7.77M
Current Leases
0.06M0.06M0.06M0.06M0.06M
Current Deferred Revenue
3.70M2.40M1.79M2.08M2.40M2.93M2.65M2.36M2.37M2.14M2.40M1.79M1.31M0.90M0.57M0.48M0.54M0.48M0.49M0.58M
Total Current Liabilities
8.20M7.51M6.29M6.69M5.96M6.81M7.97M8.44M7.17M7.29M8.07M6.64M5.13M4.98M4.70M6.43M7.44M18.08M17.94M20.39M
Non-Current Liabilities
Capital Leases
0.14M0.12M0.11M0.10M0.08M
Non-Current Debt
7.76M8.38M0.47M0.42M0.37M
Non-Current Deffered Revenue
0.38M0.32M0.18M0.11M0.25M0.26M0.24M0.29M0.53M0.35M0.18M0.10M0.02M0.01M0.00M
Preferred Stock Liabilities
Minority Interest
-0.06M-0.13M-0.17M
Operating Leases
0.64M1.85M2.52M2.40M1.99M1.88M1.76M1.64M1.52M1.40M1.28M1.16M1.03M0.93M2.81M2.87M3.84M3.65M3.44M
Other Non-Current Liabilities
0.36M0.34M0.10M1.33M2.20M0.60M1.40M1.40M1.30M1.30M0.95M
Total Non-Current Liabilities
8.20M7.81M8.42M8.77M9.44M9.67M20.05M21.71M25.40M25.01M27.18M
Total Liabilities
8.56M8.15M8.52M9.54M8.54M8.92M10.11M11.64M10.27M10.32M11.22M9.49M7.68M7.33M6.88M21.45M23.11M26.70M26.31M28.13M
Shareholder's Equity
Total Debt
1.27M1.26M7.92M8.72M8.82M7.72M8.14M
Common Equity
32.47M25.54M21.04M14.84M9.86M4.80M6.99M2.11M0.05M0.41M0.58M6.35M7.67M7.95M4.41M4.58M2.53M-1.55M-1.27M-3.99M
Liabilities and Shareholders Equity
41.02M33.69M29.56M24.38M18.40M13.72M17.10M13.75M10.32M10.73M11.80M15.84M15.35M15.28M11.28M26.03M25.64M25.15M25.04M24.14M
Retained Earnings
-48.23M-55.62M-61.00M-67.95M-73.40M-79.47M-81.20M-86.70M-88.80M-93.05M-96.81M-98.74M-101.40M-104.19M-108.10M-113.10M-118.50M-125.36M-133.04M-138.52M
Preferred Shares
1.00M

Vivos Therapeutics Balance Sheet API

Pull Vivos Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VVOS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY